Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
54.2M
-
Shares change
-
+1.55M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
+$43.4M
-
Put/Call ratio
-
0.18
-
Number of buys
-
106
-
Number of sells
-
-100
-
Price
-
$28.92
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2022
244 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2022.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.2M shares
of 56M outstanding shares and own 96.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.8M shares), VANGUARD GROUP INC (5.62M shares), ARMISTICE CAPITAL, LLC (4.71M shares), MACQUARIE GROUP LTD (2.34M shares), DIMENSIONAL FUND ADVISORS LP (2.24M shares), STATE STREET CORP (1.98M shares), GW&K Investment Management, LLC (1.91M shares), Stephens Investment Management Group LLC (1.61M shares), LOOMIS SAYLES & CO L P (1.61M shares), and RENAISSANCE TECHNOLOGIES LLC (1.4M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.